The promyelocytic leukemia phenotype is directly determined by pml/rara fusion protein expression in normal human hematopoietic progenitors

F. Gnanani, M. Valtien, M. Gobbianelli, V. Gelmetti, L. Luchetti, B. Mosella, E. Pelosi, P. Samoggia, C. Zanetti, R. Botta, O. Morsilll, P. G. Pelicci, C. Peschle

Research output: Contribution to journalArticle

Abstract

The role of fusion genes in acute myelogenous leukemia has been studied in leukemic cell lines and transgenic mice. These models bear intrinsic limitations due to the transformed nature of cell lines and the secondary genetic events that may occur in the animal We therefore directly studied the effects of acute promyelocytic leukemia (APL) PML/RARa fusion protein expression in human early hematopoietic progenitor cells (HPCs) purified from normal peripheral blood (PB) We took advantage of a novel gene transfer methodology, based on retroviral vector carrying a green 'fluorescent protein cDNA as a selectable marker: infected HPCs can be purified to homogeneity by cell sorting. HPCs expressing PML/RARa are rapidly induced îo differentiate to the promyelocytic stage and are largely blocked at this stage. These cells are markedly resistant to growth factor deprivation, and differentiate upon retinoic acid treatment Moreover unilineage or multilineage liquid suspension and clonogenic cultures demonstrated that PML/RARa expressing HPCs preferentially differentiate through the granulopoietic pathway ana are partially independent of growth factor stimulation. This has been formally demonstrated at single cell level by infecting two sibling HPCs with control or PML/RARa retroviruses. PML/RARa cells developed along the granulocytic pathway in the presence of saturating erythropoietin concentrations, that consistently channel control cells into erythroid differentiation. These findings indicate that the APL cell phentoype is determined by fusion gene expression: the leukemogenetic event may occur in eorly HPCs, whose development is determined by the oncogenic protein.

Original languageEnglish
Pages (from-to)810
Number of pages1
JournalExperimental Hematology
Volume26
Issue number8
Publication statusPublished - 1998

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Genetics
  • Hematology
  • Oncology
  • Transplantation

Fingerprint Dive into the research topics of 'The promyelocytic leukemia phenotype is directly determined by pml/rara fusion protein expression in normal human hematopoietic progenitors'. Together they form a unique fingerprint.

  • Cite this

    Gnanani, F., Valtien, M., Gobbianelli, M., Gelmetti, V., Luchetti, L., Mosella, B., Pelosi, E., Samoggia, P., Zanetti, C., Botta, R., Morsilll, O., Pelicci, P. G., & Peschle, C. (1998). The promyelocytic leukemia phenotype is directly determined by pml/rara fusion protein expression in normal human hematopoietic progenitors. Experimental Hematology, 26(8), 810.